Patents by Inventor Sehoan Kim

Sehoan Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
    Publication number: 20230000821
    Abstract: Indole carboxamide compounds of Formula (II) or pharmaceutically acceptable salt thereof have activity of inhibiting production of prostaglandin E2 (PGE2) through inhibition of microsomal prostaglandin E2 synthase-1 (mPGES-1). The indole carboxamide compounds and salts can be effectively used in treating or preventing inflammation, arthritis, high fever, pain, cancer, stroke or brain diseases such as Alzheimer's disease. A pharmaceutical composition contains the indole carboxamide compound as an active ingredient.
    Type: Application
    Filed: August 26, 2020
    Publication date: January 5, 2023
    Applicant: KUKJE PHARMA CO., LTD.
    Inventors: Younghoon KIM, Juhee LEE, Changmin PARK, Sehoan KIM, Jungmin SEO, Shinyoung LEE, Sooin CHAE, Younggwan KIM
  • Compound for inhibiting 11?-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same
    Patent number: 9073830
    Abstract: Disclosed are a novel compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition including the same for inhibiting human 11-?-hydroxy steroid dehydrogenase type 1 (11?-HSD1). The disclosed compound and the pharmaceutical composition including the same for inhibiting human 11-?-hydroxy steroid dehydrogenase type 1 (11?-HSD1) are excellent in activity and solubility, and is more efficient in formulation and transfer.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: July 7, 2015
    Assignee: Hyundai Pharm Co., Ltd.
    Inventors: Inhee Lee, Doohyeok Pyeon, Myounghyeon Shin, Jeongun Hwang, Changmin Park, Sehoan Kim, Heeil Chae, Soonyoung Moon, Soyoun Kim, Jaekeol Rhee
  • A COMPOUND FOR INHIBITING 11B-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Publication number: 20140206875
    Abstract: Disclosed are a novel compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition including the same for inhibiting human 11-?-hydroxy steroid dehydrogenase type 1 (11?-HSD1). The disclosed compound and the pharmaceutical composition including the same for inhibiting human 11-?-hydroxy steroid dehydrogenase type 1 (11?-HSD1) are excellent in activity and solubility, and is more efficient in formulation and transfer.
    Type: Application
    Filed: August 6, 2012
    Publication date: July 24, 2014
    Applicant: HYUNDAI PHARM CO., LTD.
    Inventors: Inhee Lee, Doohyeok Pyeon, Myounghyeon Shin, Jeongun Hwang, Changmin Park, Sehoan Kim, Heeil Chae, Soonyoung Moon, Soyoun Kim, Jaekeol Rhee